My Treatment Approach: Modern Perspectives on the Management of Chronic Phase CML (CP-CML) - Episode 1
Drs. Elias Jabbour and Michael Mauro discuss how patient comorbidities influence the selection of frontline tyrosine kinase inhibitor (TKI) therapy in chronic phase CML, highlighting specific comorbidity-TKI combinations to avoid and strategies for optimizing individualized treatment.